Terminal complement complexes in acute poststreptococcal glomerulonephritis

[1]  S. Hulton,et al.  Mesangiocapillary glomerulonephritis associated with meningococcal meningitis, C3 nephritis factor and persistently low complement C3 and C5 , 1992, Pediatric Nephrology.

[2]  H. Abboud Growth factors and the mesangium. , 1992, Journal of the American Society of Nephrology : JASN.

[3]  M. Schönermark,et al.  Immune damage to the mesangium: antibody- and complement-mediated stimulation and destruction of mesangial cells. , 1992, Journal of the American Society of Nephrology : JASN.

[4]  H. Abboud,et al.  Platelet-derived growth factor and mesangial cells. , 1992, Kidney international.

[5]  C. Ruef,et al.  Interleukin-6: an autocrine regulator of mesangial cell growth. , 1992, Kidney international.

[6]  G. Hänsch,et al.  Complement in inflammation: induction of nephritides and progress to chronicity. , 1991, International archives of allergy and applied immunology.

[7]  R. Wyatt,et al.  Plasma terminal complement complexes in acute poststreptococcal glomerulonephritis. , 1991, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[8]  F. Stapleton,et al.  Changing perspectives in children hospitalized with poststreptococcal acute glomerulonephritis , 1990, Pediatric Nephrology.

[9]  G. Biesecker The complement SC5b-9 complex mediates cell adhesion through a vitronectin receptor. , 1990, Journal of immunology.

[10]  B. Morgan Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects. , 1989, The Biochemical journal.

[11]  K. Preissner,et al.  Complement S-protein (vitronectin) is associated with cytolytic membrane-bound C5b-9 complexes. , 1988, Clinical and experimental immunology.

[12]  R. Wyatt,et al.  Complement profiles in acute post-streptococcal glomerulonephritis , 1988, Pediatric Nephrology.

[13]  K. Resch,et al.  Activation of glomerular mesangial cells by the terminal membrane attack complex of complement. , 1987, Journal of immunology.

[14]  J. Tschopp,et al.  Effect of nephritic factor on C3 and on the terminal pathway of complement in vivo and in vitro. , 1986, Clinical and experimental immunology.

[15]  H. Rus,et al.  Immunohistochemical detection of the terminal C5b-9 complement complex in children with glomerular diseases. , 1986, Clinical and experimental immunology.

[16]  A. Michael,et al.  Cell populations and membrane attack complex in glomeruli of patients with post-streptococcal glomerulonephritis: identification using monoclonal antibodies by indirect immunofluorescence. , 1984, Clinical immunology and immunopathology.

[17]  D. Salant,et al.  A new role for complement in experimental membranous nephropathy in rats. , 1980, The Journal of clinical investigation.

[18]  W. Kolb,et al.  The membrane attack mechanism of complement. Isolation and subunit composition of the C5b-9 complex , 1975, The Journal of experimental medicine.

[19]  C. Chantler,et al.  Plasma C3 and C4 Concentrations in Management of Glomerulonephritis , 1973, British medical journal.

[20]  H. Müller-Eberhard,et al.  THE MEMBRANE ATTACK MECHANISM OF COMPLEMENT , 1973, The Journal of experimental medicine.

[21]  R. T. ten Bensel,et al.  Serial complement component alterations in acute glomerulonephritis and systemic lupus erythematosus. , 1969, Clinical and experimental immunology.

[22]  C. West,et al.  SERUM LEVELS OF BETA-1C GLOBULIN, A COMPLEMENT COMPONENT, IN THE NEPHRITIDES, LIPOID NEPHROSIS, AND OTHER CONDITIONS. , 1964, The Journal of clinical investigation.

[23]  W. Couser,et al.  Increased urinary excretion of C5b-9 distinguishes passive Heymann nephritis in the rat. , 1989, Kidney international.

[24]  M. Kazatchkine,et al.  Immunohistochemical study of complement S protein (Vitronectin) in normal and diseased human kidneys: relationship to neoantigens of the C5b-9 terminal complex. , 1989, Clinical and experimental immunology.

[25]  H. Müller-Eberhard The membrane attack complex of complement. , 1986, Annual review of immunology.